Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 20, 2023 07:30 ET | Source: Advent Therapeutics, Inc.

Advent Therapeutics Receives FDA Rare Pediatric Disease Designation for Retinol Palmitate for Prevention of Bronchopulmonary Dysplasia in Premature Infants

Reinventing Vitamin A for neonatal and pediatric unmet medical needsBronchopulmonary Dysplasia (BPD) is most frequent serious complication of preterm birth – US preterm births highest in 15...
July 18, 2023 07:30 ET | Source: Advent Therapeutics, Inc.

Advent Therapeutics Awarded $3 Million NIH Grant for Novel Neonatal Lung Therapy

DOYLESTOWN, Pa., July 18, 2023 (GLOBE NEWSWIRE) -- Advent Therapeutics, Inc., a biotechnology company pioneering an optimized retinol palmitate (vitamin A) drug product as a breakthrough...